Nutex Health Inc is a physician-led, healthcare services and operations company with various hospital facilities in the U... Show more
A.I.dvisor indicates that over the last year, NUTX has been closely correlated with SMSI. These tickers have moved in lockstep 87% of the time. This A.I.-generated data suggests there is a high statistical probability that if NUTX jumps, then SMSI could also see price increases.
| Ticker / NAME | Correlation To NUTX | 1D Price Change % | ||
|---|---|---|---|---|
| NUTX | 100% | +14.28% | ||
| SMSI - NUTX | 87% Closely correlated | +0.86% | ||
| DDI - NUTX | 31% Poorly correlated | +3.46% | ||
| VHC - NUTX | 31% Poorly correlated | +4.28% | ||
| SSNC - NUTX | 27% Poorly correlated | -1.62% | ||
| XBP - NUTX | 27% Poorly correlated | +5.32% | ||
More | ||||
| Ticker / NAME | Correlation To NUTX | 1D Price Change % |
|---|---|---|
| NUTX | 100% | +14.28% |
| NUTX (2 stocks) | 100% Closely correlated | -5.87% |
| Hospital/Nursing Management (48 stocks) | 10% Poorly correlated | +5.24% |
| Health Services (239 stocks) | -1% Poorly correlated | +4.23% |
Industry HospitalNursingManagement
The Aroon Indicator for NUTX entered a downward trend on November 04, 2026. Tickeron's A.I.dvisor identified a pattern where the AroonDown red line was above 70 while the AroonUp green line was below 30 for three straight days. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options. A.I.dvisor looked at 210 similar instances where the Aroon Indicator formed such a pattern. In 195 of the 210 cases the stock moved lower. This puts the odds of a downward move at 90%.
The Moving Average Convergence Divergence Histogram (MACD) for NUTX turned negative on November 02, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 42 similar instances when the indicator turned negative. In 35 of the 42 cases the stock turned lower in the days that followed. This puts the odds of success at 83%.
The 10-day moving average for NUTX crossed bearishly below the 50-day moving average on November 03, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 10 of 12 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 83%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where NUTX declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 89%.
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where NUTX's RSI Indicator exited the oversold zone, 24 of 25 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 90%.
The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.
The Momentum Indicator moved above the 0 level on November 04, 2026. You may want to consider a long position or call options on NUTX as a result. In 81 of 92 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 88%.
NUTX moved above its 50-day moving average on November 04, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +6.06% 3-day Advance, the price is estimated to grow further. Considering data from situations where NUTX advanced for three days, in 218 of 252 cases, the price rose further within the following month. The odds of a continued upward trend are 87%.
NUTX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron PE Growth Rating for this company is 3 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 19 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is 45 (best 1 - 100 worst), indicating steady price growth. NUTX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 58 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.564) is normal, around the industry mean (204.059). P/E Ratio (7.660) is within average values for comparable stocks, (18.581). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.498). Dividend Yield (0.000) settles around the average of (0.091) among similar stocks. P/S Ratio (1.830) is also within normal values, averaging (2.688).
The Tickeron Seasonality Score of 85 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. NUTX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 82, placing this stock worse than average.